PETERSEN, Peter C.; PETERSEN, Lone N.; VOGELIUS, Ivan; BJERREGAARD, Jon K.; BAEKSGAARD, Lene. A randomized phase 2 trial of first-line docetaxel, carboplatin, capecitabine (CTX) and epirubicin, oxaliplatin, capecitabine (EOX) in advanced esophagogastric adenocarcinoma. Acta Oncologica, [S. l.], v. 60, n. 7, p. 948–953, 2021. DOI: 10.1080/0284186X.2021.1928281. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/24015. Acesso em: 24 jun. 2026.